Background Crassostrea ariakensis Gould is a representative bivalve species and an economically important oyster in China, but suffers severe mortalities in recent years that are caused by rickettsia-like organism (RLO). Prevention and control of this disease is a priority for the development of oyster aquaculture. It has been proven that mammalian HMGB (high mobility group box) can be released extracellularly and acts as an important pro-inflammatory cytokine and late mediator of inflammatory reactions. In vertebrates, HMGB’s antibody (anti-HMGB) has been shown to confer significant protection against certain local and systemic inflammatory diseases. Therefore, we investigated the functions of Ca-HMGB (oyster HMGB) and anti-CaHMGB (Ca-HMGB’s antibody) in oyster RLO/LPS (RLO or LPS)-induced disease or inflammation. Methodology/Principal Findings Sequencing analysis revealed Ca-HMGB shares conserved structures with mammalians. Tissue-specific expression indicates that Ca-HMGB has higher relative expression in hemocytes. Significant continuous up-regulation of Ca-HMGB was detected when the hemocytes were stimulated with RLO/LPS. Recombinant Ca-HMGB protein significantly up-regulated the expression levels of some cytokines. Indirect immunofluorescence study revealed that Ca-HMGB localized both in the hemocyte nucleus and cytoplasm before RLO challenge, but mainly in the cytoplasm 12 h after challenge. Western blot analysis demonstrated Ca-HMGB was released extracellularly 4–12 h after RLO challenge. Anti-CaHMGB was added to the RLO/LPS-challenged hemocyte monolayer and real-time RT-PCR showed that administration of anti-CaHMGB dramatically reduced the rate of RLO/LPS-induced up-regulation of LITAF at 4–12 h after treatment. Flow cytometry analysis indicated that administration of anti-CaHMGB reduced RLO/LPS-induced hemocyte apoptosis and necrosis rates. Conclusions/Significance Ca-HMGB can be released extracellularly and its subcellular localization varies when stimulated with RLO. Ca-HMGB is involved in oyster immune reactions and functions as a pro-inflammatory cytokine. Anti-CaHMGB can significantly suppress RLO/LPS-induced inflammatory responses and hemocyte necrosis and apoptosis, suggesting that Ca-HMGB is a potential target to prevent and control RLO/LPS-induced disease or inflammation.
Bachere E, Gueguen Y, Gonzalez M, de Lorgeril J, Garnier J, et al. (2004) Insights into the anti-microbial defense of marine invertebrates: the penaeid shrimps and the oyster Crassostrea gigas. Immunol Rev 198: 149–168.
[3]
Hooper C, Day R, Slocombe R, Handlinger J, Benkendorff K (2007) Stress and immune responses in abalone: limitations in current knowledge and investigative methods based on other models. Fish Shellfish Immunol 22: 363–379.
[4]
Flajnik MF, Du Pasquier L (2004) Evolution of innate and adaptive immunity: can we draw a line? Trends Immunol 25: 640–644.
[5]
Hanington PC, Forys MA, Dragoo JW, Zhang SM, Adema CM, et al. (2010) Role for a somatically diversified lectin in resistance of an invertebrate to parasite infection. Proc Natl Acad Sci U S A 107: 21087–21092.
[6]
Kurtz J, Armitage SA (2006) Alternative adaptive immunity in invertebrates. Trends Immunol 27: 493–496.
[7]
Litman GW, Cannon JP, Rast JP (2005) New insights into alternative mechanisms of immune receptor diversification. Adv Immunol 87: 209–236.
[8]
Loker ES, Adema CM, Zhang SM, Kepler TB (2004) Invertebrate immune systems–not homogeneous, not simple, not well understood. Immunol Rev 198: 10–24.
[9]
Wu LJ, Wu XZ, Deng HK, Huang YQ (2010) First identification and functional analysis of a histidine triad nucleotide binding protein in an invertebrate species Haliotis diversicolor supertexta. Dev Comp Immunol 34: 76–83.
[10]
Wu LJ, Wu XZ, Zhu BJ, Cao XH (2009) Identification and functional characterization of a novel cytidine deaminase in a gastropod abalone, Haliotis diversicolor supertexta. Dev Comp Immunol 33: 709–717.
[11]
Yang SB, Wu XZ (2010) Identification and functional characterization of a human sTRAIL homolog, CasTRAIL, in an invertebrate oyster Crassostrea ariakensis. Develop Comp Immunol 34: 538–545.
[12]
Zhu BJ, Wu XZ (2008) Characterization and function of CREB homologue from Crassostrea ariakensis stimulated by rickettsia-like organism. Develop Comp Immunol 32: 1572–1581.
[13]
Zhang SM, Adema CM, Kepler TB, Loker ES (2004) Diversification of Ig superfamily genes in an invertebrate. Science 305: 251–254.
[14]
Zhang SM, Nian H, Zeng Y, Dejong RJ (2008) Fibrinogen-bearing protein genes in the snail Biomphalaria glabrata: characterization of two novel genes and expression studies during ontogenesis and trematode infection. Dev Comp Immunol 32: 1119–1130.
[15]
Lee Y, De Zoysa M, Whang I, Lee S, Kim Y, et al. (2011) Molluscan death effector domain (DED)-containing caspase-8 gene from disk abalone (Haliotis discus discus): molecular characterization and expression analysis. Fish Shellfish Immunol 30: 480–487.
[16]
De Zoysa M, Nikapitiya C, Kim Y, Oh C, Kang DH, et al. (2010) Allograft inflammatory factor-1 in disk abalone (Haliotis discus discus): molecular cloning, transcriptional regulation against immune challenge and tissue injury. Fish Shellfish Immunol 29: 319–326.
[17]
Wu XZ, Pan JP (2000) An intracellular prokaryotic microorganism associated with lesions in the oyster, Crassostrea ariakensis Gould. J Fish Dis 23: 409–414.
[18]
Sun JF, Wu XZ (2004) Histology, ultrastructure, and morphogenesis of a rickettsia-like organism causing disease in the oyster, Crassostrea ariakensis Gould. J Invertebr Pathol 86: 77–86.
[19]
Chen SC, Wang PC, Tung MC, Thompson K, Adams A (2000) A Piscirickettsia salmonis-like organism in grouper, Epinephelus melanostigma, in Taiwan.,. J Fish Dis 23: 415–418.
[20]
Ilan P (1977) Epitheliocystis infection in wild and cultured sea bream (Sparus aurata, Sparidae) and grey mullets (Liza ramada, Mugilidae). Aquaculture 10: 169–176.
[21]
Fryer JL, Lannan CN (1996) Rickettsila infecions of fish. Annu Rev Fish Dis 6: 3–13.
[22]
Bonami JR, Pappalardo R (1980) Rickettsial infection in marine crustacea. Experientia 36: 180–181.
[23]
Federici BA, Hazard EI, Anthony DW (1974) Rickettsia-like organism causing disease in a crangonid amphipod from Florida. Appl Microbiol 28: 885–886.
[24]
Comps M, Bonami J-R, Vago C (1977) Pathology des inverte’bre’s. - Mise en e’vidence d’une infection rickettsienne chez les Huitres. CR Acad Sc Paris, t 285: 427–429.
[25]
Wu XZ (2003) Advances in the research of marine-cultured animal diseases in China. In: Lee C-S, Ventura A, editors. Status of Aquaculture in China. Hawaii, USA in Honolulu: The Oceanic Institute. 29–54.
[26]
Harshbarger JC, Chang SC (1977) Chlamydiae (with phages), mycoplasmas, and richettsiae in Chesapeake Bay bivalves. Science 196: 666–668.
[27]
Yang SB, Wu XZ (2009) Tolliod-like gene in Crassostrea ariakensis: Molecular cloning, structural characterization and expression by RLO stimulation. Fish Shellfish Immunol 27: 130–135.
[28]
Zhu BJ, Wu XZ (2008) Identification of outer membrane protein ompR from rickettsia-like organism and induction of immune response in Crassostrea ariakensis. Mol Immunol 45: 3198–3204.
[29]
Xu T, Xie JS, Li JM, Luo M, Ye SG, et al. (2012) Identification of expressed genes in cDNA library of hemocytes from the RLO-challenged oyster, Crassostrea ariakensis Gould with special functional implication of three complement-related fragments (CaC1q1, CaC1q2 and CaC3). Fish Shellfish Immunol 32: 1106–1116.
[30]
Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ (2002) HMGB1 as a DNA-binding cytokine. J Leukoc Biol 72: 1084–1091.
[31]
Bustin M (1999) Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 19: 5237–5246.
[32]
Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248–251.
[33]
Wang SB, Yao YM (2003) Extracellular effect of high mobility group box-1 protein and its role in sepsis: an overview. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 15: 701–704.
[34]
Huang W, Tang Y, Li L (2010) HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 51: 119–126.
[35]
Chen G, Ward MF, Sama AE, Wang H (2004) Extracellular HMGB1 as a proinflammatory cytokine. J Interferon Cytokine Res 24: 329–333.
[36]
Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331–342.
[37]
Yang H, Ochani M, Li J, Qiang X, Tanovic M, et al. (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 101: 296–301.
[38]
Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, et al. (2003) Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101: 2652–2660.
[39]
Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, et al. (2009) HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462: 99–103.
[40]
Li DF, Wu XZ (2004) Purification and biological features of a rickettsia-like prokaryote from the scallop Argopecten irradians in China. Aquaculture 234: 29–40.
[41]
Lacoste A, Cueff A, Poulet SA (2002) P35-sensitive caspases, MAP kinases and Rho modulate beta-adrenergic induction of apoptosis in mollusc immune cells. J Cell Sci 115: 761–768.
[42]
Canesi L, Lorusso LC, Ciacci C, Betti M, Zampini M, et al. (2004) Environmental estrogens can affect the function of mussel hemocytes through rapid modulation of kinase pathways. Gen Comp Endocrinol 138: 58–69.
[43]
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.
[44]
Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101–1108.
[45]
Brockton V, Henson JH, Raftos DA, Majeske AJ, Kim YO, et al. (2008) Localization and diversity of 185/333 proteins from the purple sea urchin–unexpected protein-size range and protein expression in a new coelomocyte type. J Cell Sci 121: 339–348.
[46]
Bustin M (2001) Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci 26: 152–153.
[47]
Canaple L, Decoville M, Leng M, Locker D (1997) The Drosophila DSP1 gene encoding an HMG 1-like protein: genomic organization, evolutionary conservation and expression. Gene 184: 285–290.
[48]
de Oliveira FM, de Abreu da Silva IC, Rumjanek FD, Dias-Neto E, Guimaraes PE, et al. (2006) Cloning the genes and DNA binding properties of High Mobility Group B1 (HMGB1) proteins from the human blood flukes Schistosoma mansoni and Schistosoma japonicum. Gene 377: 33–45.
[49]
Canesi L, Gallo G, Gavioli M, Pruzzo C (2002) Bacteria-hemocyte interactions and phagocytosis in marine bivalves. Microsc Res Tech 57: 469–476.
[50]
Mitta G, Vandenbulcke F, Noel T, Romestand B, Beauvillain JC, et al. (2000) Differential distribution and defence involvement of antimicrobial peptides in mussel. J Cell Sci 113 (Pt 15): 2759–2769.
[51]
Chen YH, Jia XT, Huang XD, Zhang S, Li M, et al. (2011) Two Litopenaeus vannamei HMGB proteins interact with transcription factors LvSTAT and LvDorsal to activate the promoter of white spot syndrome virus immediate-early gene ie1. Mol Immunol 48: 793–799.
[52]
Youn JH, Oh YJ, Kim ES, Choi JE, Shin JS (2008) High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J Immunol 180: 5067–5074.
[53]
Wang H, Vishnubhakat JM, Bloom O, Zhang M, Ombrellino M, et al. (1999) Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126: 389–392.
[54]
Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, et al. (2003) Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22: 5551–5560.
[55]
Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, et al. (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 3: 995–1001.
[56]
Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, et al. (2000) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192: 565–570.
[57]
Park JS, Arcaroli J, Yum HK, Yang H, Wang H, et al. (2003) Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 284: C870–879.
[58]
Yu M, Wang H, Ding A, Golenbock DT, Latz E, et al. (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26: 174–179.
[59]
Gnanasekar M, Velusamy R, He YX, Ramaswamy K (2006) Cloning and characterization of a high mobility group box 1 (HMGB1) homologue protein from Schistosoma mansoni. Mol Biochem Parasitol 145: 137–146.
[60]
Park JM, Greten FR, Wong A, Westrick RJ, Arthur JS, et al. (2005) Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis–CREB and NF-kappaB as key regulators. Immunity 23: 319–329.
[61]
Tang X, Marciano DL, Leeman SE, Amar S (2005) LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines. Proc Natl Acad Sci U S A 102: 5132–5137.
[62]
Ludviksson BR, Gunnlaugsdottir B (2003) Transforming growth factor-beta as a regulator of site-specific T-cell inflammatory response. Scand J Immunol 58: 129–138.
[63]
Wang D, Noda Y, Zhou Y, Nitta A, Nabeshima T, et al. (2004) Effects of sodium houttuyfonate on phosphorylation of CaMK II, CREB and ERK 1/2 and expression of c-Fos in macrophages. Int Immunopharmacol 4: 1083–1088.
[64]
Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135–145.
[65]
Takano T, Kondo H, Hirono I, Saito-Taki T, Endo M, et al. (2006) Identification and characterization of a myeloid differentiation factor 88 (MyD88) cDNA and gene in Japanese flounder, Paralichthys olivaceus. Dev Comp Immunol 30: 807–816.
[66]
Utans U, Arceci RJ, Yamashita Y, Russell ME (1995) Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 95: 2954–2962.
[67]
Utans U, Quist WC, McManus BM, Wilson JE, Arceci RJ, et al. (1996) Allograft inflammatory factory-1. A cytokine-responsive macrophage molecule expressed in transplanted human hearts. Transplantation 61: 1387–1392.
